Influence of feeding enzymatically hydrolysed yeast cell wall + yeast culture on growth performance of calf-fed Holstein steers

Salinas-Chavira, J.; Montaño, M. F.; Torrentera, N.; Zinn, R. A.

doi:10.1080/09712119.2017.1299742

Cited by 21 publications

(19 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There were no appreciable differences detected for performance-based dietary NE m ( P = 0.70) or NE g ( P = 0.59) in the present study. This is similar to what others have reported in response to the use of a yeast culture-based product in shipping-stressed calves and growing–finishing Holstein steers ( Zinn et al, 1999 ; Salinas-Chavira et al, 2018 ). Likewise, there were no differences detected between treatments for the ratio of observed to expected dietary NE m ( P = 0.70) or the ratio of observed to expected dietary NE g ( P = 0.59), which is similar to what others have demonstrated in a transit-stressed calf model, as well as growing and finishing Holstein steers ( Zinn et al, 1999 ; Salinas-Chavira et al, 2018 ).…”

Section: Resultssupporting

confidence: 90%

“…When a live yeast Saccharomyces cerevisiae boulardii CNCM I-1079 was fed to high-risk receiving heifers, improvements in growth performance during the initial 45 d on feed, as well as improved health outcomes, were noted ( Theurer et al, 2019 ). When an enzymatically hydrolyzed yeast was fed to growing Holstein steers, a 3.4 % increase in ADG and a 3.4 % increase in DMI was noted and steers exhibited similar feed efficiency ( Salinas-Chavira et al, 2018 ). However, when enzymatically hydrolyzed yeast was fed to crossbred beef steers, a 9% increase in ADG was observed during the finishing phase of production ( Salinas-Chavira et al, 2015 ).…”

Section: Resultsmentioning

confidence: 99%

“…The current Veterinary Feed Directive and implementation of all-natural beef marketing channels have created the need for nonantimicrobial feed additives that have the potential to improve feed conversion efficiency, aid in ruminal fermentation, and improve animal health outcomes. Feeding enzymatically hydrolyzed yeast, yeast culture products, and active live yeast strains of Saccharomyces cerevisiae (SC) to cattle has produced inconsistent results in relation to gain, intake, gain efficiency, and efficiency of dietary net energy (NE) utilization ( Zinn et al, 1999 ; Finck et al, 2014 ; Salinas-Chavira et al, 2015 ; Kayser et al, 2016 ; Ovinge et al, 2018 ; Salinas-Chavira et al, 2018 ). The objective of this experiment was to evaluate the influence of an active live yeast product (Levucell SC, Advantage Titan, CNCM l-1077, Lallemand Animal Nutrition, Milwaukee, WI) on receiving and backgrounding period growth performance and efficiency of dietary NE utilization in low health risk beef steers.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Evaluation of an active live yeast (Levucell Saccharomyces cerevisiae, CNCM l-1077) on receiving and backgrounding period growth performance and efficiency of dietary net energy utilization in low health risk beef steers1

Smith

Karges²,

Aguilar³

2020

Translational Animal Science

View full text Add to dashboard Cite

The objective of this experiment was to evaluate the influence of an active live yeast direct-fed microbial (DFM) product on receiving and backgrounding period growth performance and efficiency of dietary net energy (NE) utilization in low health risk beef steers. Maine-Anjou × Angus steers (n = 199; body weight [BW] = 252 ± 32.1 kg) were received from two sources at the Ruminant Nutrition Center in Brookings, SD, in November 2019 and used in a 77-d feedlot receiving and backgrounding experiment. Steers were provided access to long-stem hay and ad libitum water upon arrival. Steers were weighed, vaccinated for respiratory pathogens (source 2 only): infectious bovine rhinotracheitis, bovine viral diarrhea types 1 and 2, parainfluenza-3 virus, and bovine respiratory syncytial virus (Bovi-Shield Gold 5, Zoetis, Parsippany, NJ) vaccinated for clostridial species (Ultrabac 7/Somubac, Zoetis) and pour-on moxidectin (Cydectin, Bayer, Shawnee Mission, KS). Steers (n = 176 steers; initial unshrunk BW = 235 ± 27.6 kg) were allotted to pens (n = 20 pens; 10 pens per treatment; eight or nine steers per pen). Diets were based upon corn silage, dry-rolled corn, and dried distillers grains; dietary treatments were 1) no DFM (CON) and 2) DFM (Levucell SC, Advantage Titan, CNCM l-1077), fed at 10 g/steer/d providing 8 × 109 CFU of active live yeast to each steer daily (DFM). Initial BW was the average of day −1 and day 1 BW (n = 176 steers; initial BW = 253 ± 27.6 kg). On day 21, steers received a 200-mg progesterone and 20-mg estradiol benzoate implant. Data were analyzed from day 1 to 47 (receiving period), day 48 to 77, and from day 1 to 77 as a randomized complete block design; pen served as the experimental unit for all analyses. On day 47 of the experiment, DFM had greater BW (P = 0.01) by 0.9% and average daily gain (ADG; P = 0.01) by 4.2% and gain-to-feed ratio (G:F) tended (P = 0.13) to be 2.8% greater. Day 77 BW did not differ (P = 0.60), cumulative (days 1–77): ADG (P = 0.47), dry matter intake (P = 0.66), and G:F (P = 0.56) were similar. Yeast inclusion had no appreciable influence on performance-based dietary NE utilization or the ratio of observed/expected dietary NE (P ≥ 0.59). In low health risk steers, DFM improved performance during the feedlot receiving period. However, no improvements for DFM were detected for cumulative performance from day 1 to 77. The confirmation of yeast counts indicated the CFU to be above the expected level at the start of the trial but was found below expected level at the end of the trial. This may explain differences during the initial 47 d compared to cumulative growth performance results.

show abstract

Section: Resultssupporting

confidence: 90%

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of an active live yeast (Levucell Saccharomyces cerevisiae, CNCM l-1077) on receiving and backgrounding period growth performance and efficiency of dietary net energy utilization in low health risk beef steers1

Smith

Karges²,

Aguilar³

2020

Translational Animal Science

View full text Add to dashboard Cite

show abstract

“…Alternatively, increased ADG of Celmanax-supplemented ruminants has been associated with increased DM intake (Ponce et al, 2012;Nde et al, 2014). Supplementing S. cerevisiae-derived products to cattle may improve ruminal fiber degradation and microbial protein synthesis (Miller-Webster et al, 2002;Salinas-Chavira et al, 2015;Salinas-Chavira et al, 2017), which in turn regulate DM intake in ruminants (Allen, 1996). Accordingly, Ponce et al (2012) reported greater concentrate intake, but similar hay intake and overall feed efficiency, in Celmanax-supplemented compared with non-supplemented heifers during feedlot receiving.…”

Section: Discussionmentioning

confidence: 99%

Supplementing a yeast-derived product to enhance productive and health responses of beef steers

Silva

Cooke

Schubach

et al. 2018

Animal

View full text Add to dashboard Cite

This experiment evaluated the impacts of supplementing a yeast-derived product (Celmanax; Church & Dwight Co., Inc., Princeton, NJ, USA) on productive and health responses of beef steers, and was divided into a preconditioning (days 4 to 30) and feedlot receiving phase (days 31 to 69). In all, 84 Angus × Hereford steers were weaned on day 0 (BW=245±2 kg; age=186±2 days), and maintained in a single group from days 0 to 3. On day 4, steers were allocated according to weaning BW and age to a 21-pen drylot (4 steers/pen). Pens were randomly assigned to (n=7 pens/treatment): (1) no Celmanax supplementation during the study, (2) Celmanax supplementation (14 g/steer daily; as-fed) from days 14 to 69 or (3) Celmanax supplementation (14 g/steer daily; as-fed) from days 31 to 69. Steers had free-choice access to grass-alfalfa hay, and were also offered a corn-based concentrate beginning on day 14. Celmanax was mixed daily with the concentrate. On day 30, steers were road-transported for 1500 km (24 h). On day 31, steers returned to their original pens for the 38-day feedlot receiving. Shrunk BW was recorded on days 4, 31 and 70. Feed intake was evaluated daily (days 14 to 69). Steers were observed daily (days 4 to 69) for bovine respiratory disease (BRD) signs. Blood samples were collected on days 14, 30, 31, 33, 35, 40, 45, 54 and 69, and analyzed for plasma cortisol, haptoglobin, IGF-I, and serum fatty acids. Preconditioning results were analyzed by comparing pens that received (CELM) or not (CONPC) Celmanax during the preconditioning phase. Feedlot receiving results were analyzed by comparing pens that received Celmanax from days 14 to 69 (CELPREC), days 31 to 69 (CELRECV) or no Celmanax supplementation (CON). During preconditioning, BRD incidence was less (P=0.03) in CELM v. CONPC. During feedlot receiving, average daily gain (ADG) (P=0.07) and feed efficiency (P=0.08) tended to be greater in CELPREC and CELRECV v. CON, whereas dry matter intake was similar (P⩾0.29) among treatments. No other treatment effects were detected (P⩾0.20). Collectively, Celmanax supplementation reduced BRD incidence during the 30-day preconditioning. Moreover, supplementing Celmanax tended to improve ADG and feed efficiency during the 38-day feedlot receiving, independently of whether supplementation began during preconditioning or after feedlot entry. These results suggest that Celmanax supplementation benefits preconditioning health and feedlot receiving performance in beef cattle.

show abstract

“…Sánchez-Mendoza et al (2015) observed that a chromium-enriched YCW increased ADG and tended to increase DMI during the first 112 d of a trial, but not the last 100 d or overall compared with no YCW. Holstein steers supplemented with 0, 195, 390, or 585 mg/kg diet DM of enzymatically hydrolyzed YCW + yeast culture for 336 d had increased overall DMI, ADG, and final carcass weight, with maximal effects observed at 195 mg/kg YCW (Salinas-Chavira et al, 2017). The inclusion of YCW for the final 55 d in steers fed zilpaterol hydrochloride resulted in increased carcass adjusted final BW, ADG, and G:F from day 21 to 55, but there were no other differences in performance or carcass characteristics (Aragon et al, 2016).…”

Section: Performancementioning

confidence: 99%

Effect of a hydrolyzed mannan- and glucan-rich yeast fraction on performance and health status of newly received feedlot cattle1

Pukrop

Brennan

Funnell

et al. 2018

Journal of Animal Science

View full text Add to dashboard Cite

A two-part experiment was conducted to determine the effects of a blend of specialized mannan rich and glucan rich fractions of yeast (Select-TC, Alltech Inc.) on the health status and performance of steers during the first two months of the feedlot period. Eighty crossbred steers were acquired from commercial sale barns in Mississippi and Georgia, and transported to Purdue University. All animals were fed a corn silage based receiving diet, and were checked and treated daily for respiratory disease as needed following established treatment protocols. In Exp. 1, 64 steers (246.5 ± 4.7 kg initial weight) were blocked by body weight (BW) and randomly allocated to 2 treatments to determine the impact of supplementation of a hydrolyzed mannan and glucan rich yeast fraction for 56 d on BW, average daily gain (ADG), daily dry matter intake (DMI), and gain:feed: hydrolyzed yeast fed at 13 g (as-fed)/steer daily (TC) or non-supplemented control (CON). Steers in Exp. 1 were housed in bedded pens with 2 animals/pen (n = 16 pens [32 steers]/treatment). In Exp. 2, 16 steers (247.1 ± 5.4 kg initial BW) were similarly allotted to two treatments (CON and TC), individually penned, and subjected to a lipopolysaccharide (LPS) endotoxin challenge on d 62 or 63 after the start of the study to determine the animal's response to an inflammatory agent. Serum samples and rectal temperatures were taken every half an hour from -2 to 8 h relative to LPS injection from steers in Exp. 2. Data were analyzed as a complete randomized block design using the MIXED procedure of SAS. Morbidity for both experiments did not differ (P ≥ 0.16). Weight, ADG, DMI and gain:feed, did not differ among treatments (P ≥ 0.32) in Exp. 1. After the LPS infusion in Exp. 2, rectal temperatures (P = 0.03) and serum non-esterified fatty acid (NEFA) concentration (P = 0.04) were decreased in TC compared to CON steers. Concentrations of blood urea nitrogen (P = 0.31), glucose (P = 0.70), insulin (P = 0.57) and cortisol (P = 0.77) did not differ by treatment after LPS administration. Serum interleukin-6 concentrations were decreased (P < 0.0001) and interferon-γ concentrations tended to be greater (P = 0.07) in TC compared to CON steers after LPS infusion. Serum cytokine and metabolite results indicate that Select TC improved health and metabolic status of LPS-challenged cattle, but this did not result in quantifiable improvements in performance in the conditions observed in this study.

show abstract

Influence of feeding enzymatically hydrolysed yeast cell wall + yeast culture on growth performance of calf-fed Holstein steers

Cited by 21 publications

References 14 publications

Evaluation of an active live yeast (Levucell Saccharomyces cerevisiae, CNCM l-1077) on receiving and backgrounding period growth performance and efficiency of dietary net energy utilization in low health risk beef steers1

Evaluation of an active live yeast (Levucell Saccharomyces cerevisiae, CNCM l-1077) on receiving and backgrounding period growth performance and efficiency of dietary net energy utilization in low health risk beef steers1

Supplementing a yeast-derived product to enhance productive and health responses of beef steers

Effect of a hydrolyzed mannan- and glucan-rich yeast fraction on performance and health status of newly received feedlot cattle1

Contact Info

Product

Resources

About